SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-24-017664
Filing Date
2024-05-03
Accepted
2024-05-03 13:31:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 60029
  Complete submission text file 0001493152-24-017664.txt   61634
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Subject) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13D | Act: 34 | File No.: 005-36989 | Film No.: 24912154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12100 WILSHIRE BOULEVARD SUITE 1275 LOS ANGELES CA 90025
Business Address
Catelani Michael (Filed by) CIK: 0001689394 (see all company filings)

Type: SC 13D